Atopic Dermatitis

Southern Medical Journal

Volumn 96, Issue 11, 2003, Pages 1068-1072

  Ahuja, Angela ^a   Land, Kelly ^a   Barnes, Cheryl J ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Atopy patch test; Emollients; Food allergy; Interleukins; Keratinocytes; Radioallergosorbent test; Xerosis

Indexed keywords

ALCLOMETASONE DIPROPIONATE; ANTIHISTAMINIC AGENT; BETAMETHASONE; BETAMETHASONE DIPROPIONATE; CEFALEXIN; CLOBETASOL PROPIONATE; CORTICOSTEROID; DESONIDE; DIFLORASONE DIACETATE; EMOLLIENT AGENT; FLUOCINONIDE; HYDROCORTISONE; HYDROCORTISONE ACETATE; HYDROCORTISONE VALERATE; LANOLIN ALCOHOL; MOMETASONE FUROATE; MONTELUKAST; PIMECROLIMUS; PSEUDOMONIC ACID; SOAP; TACROLIMUS; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; XIPAMIDE; IMMUNOGLOBULIN E;

ALGORITHM; ATOPIC DERMATITIS; AVOIDANCE BEHAVIOR; CLINICAL EXAMINATION; DISEASE SEVERITY; FOOD ALLERGY; HERPES SIMPLEX; HUMAN; IMMUNOPATHOGENESIS; IMPETIGO; INFECTION; MYCOSIS; PATCH TEST; RADIOALLERGOSORBENT TEST; REVIEW; RISK FACTOR; SKIN ATROPHY; SKIN BURNING SENSATION; STAPHYLOCOCCUS INFECTION; TREATMENT PLANNING; VERRUCA VULGARIS; IMMUNOLOGY; PATHOPHYSIOLOGY; TH2 CELL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; DERMATITIS, ATOPIC; HUMANS; IMMUNOGLOBULIN E; TH2 CELLS;

EID: 0642337430     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000097884.29305.55     Document Type: Review

References (20)

1. Engler RJ, Kenner J, Leung DY. Smallpox vaccination: Risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol 2002;110:357-365.
2. Correale CE, Walker C, Murphy L, et al. Atopic dermatitis: A review of diagnosis and treatment. Am Fam Physician 1999;60:1191-1198, 1209-1210.
3. Fitzpatrick TB, Johnson RA, Wolff K, et al. Atopic dermatitis, in Color Atlas and Synopsis of Clinical Dermatology: Common & Serious Diseases. New York, McGraw-Hill, 2001, ed 4, pp 30-35.
4. Shaw JC. Atopic dermatitis. UpToDate 2002;10:1-10. Available at: http://www.uptodate.com/physicians/rheumatology_toclist.asp#Allergy. Accessed September 17, 2003.
5. Williams HC. Epidemiology of atopic dermatitis. Clin Exp Dermatol 2000;25:522-529.
6. Larsen FS, Hanifin JM. Epidemiology of atopic dermatitis. Immunol Allergy Clin North Am 2002;22:1-25.
7. Akdis M, Trautmann A, Klunker S, et al. T cells and effector functions in atopic dermatitis. ACI Int 2002;14:61-64.
8. Fujisawa T, Fujisawa R, Kato Y, et al. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 2002;110:139-146.
9. Wollenberg A, Kraft S, Oppel T, et al. Atopic dermatitis: Pathogenetic mechanisms. Clin Exp Dermatol 2000;25:530-534.
10. Reich K, Hugo S, Middel P, et al. Evidence for a role of Langerhans cell-derived IL-16 in atopic dermatitis. J Allergy Clin Immunol 2002;109:681-687.
11. Iwasaki M, Nagata K, Takano S, et al. Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. J Invest Dermatol 2002;119:609-616.
12. Mascia F, Mariani V, Giannetti A, et al. House dust mite allergen exerts no direct proinflammatory effects on human keratinocytes. J Allergy Clin Immunol 2002;109:532-538.
13. Sicherer SH, Sampson HA. Atopic dermatitis: An update for the next millennium. J Allergy Clin Immunol 1999;104.
14. Shah D, Hales J, Cooper D, et al. Recognition of pathogenically relevant house dust mite hypersensitivity in adults with atopic dermatitis: A new approach? J Allergy Clin Immunol 2002;109:1012-1018.
15. Thestrup-Pedersen K. Environmental factors and atopic dermatitis: How could they influence disease expression? ACI Int 2002;14:165-169.
16. Slavin R. Contact dermatitis, in Patterson R, Grammer LC, Greenberger PA (eds): Allergic Diseases: Diagnosis and Management. Philadelphia, Lippincott-Raven 1997, ed 5, pp 413-424.
17. Darsow U, Ring J. Atopic eczema, allergy, and atopy patch test. ACI Int 2002;14:170-173.
18. Fleischer AB Jr, Ling M, Eichenfield L, et al. Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections. J Am Acad Dermatol 2002;47:562-570.
19. Reitamo S, Van Leent EJ, Ho V, et al; European/Canadian Tacrolimus Ointment Study Group. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002;109:539-546.
20. Yanase DJ, David-Bajar K. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis. J Am Acad Dermatol 2001;44:89-93.